Skip to main content
Equibles

BARCLAYS PLC

Position in IVVD — Invivyd, Inc.

CIK 312069 LONDON, X0
Back to IVVD Full portfolio

Position in IVVD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$71,468
-$93,295 QoQ
Shares Held
81,960
-35.3% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 124 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IVVD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. IVVD ranks #263 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in IVVD

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $71,468 81,960
2026-03-31 $164,763 126,742
2025-12-31 $728,945 295,120
2025-09-30 $476,860 433,510
2025-06-30 $23,958 33,510
2025-03-31 $68,433 113,115
2024-12-31 $56,340 127,180
2024-09-30 $120,331 117,973
2024-06-30 $46,411 42,193
2024-03-31 $900,569 202,831
2023-12-31 $284,598 72,233
2023-03-31 $31,324 26,104
2022-12-31 $20,674 13,783
2022-09-30 $6,810 2,176
2022-06-30 $8,449 2,576
2022-03-31 $43,584 9,558